Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.

Moro, Hiroshi; Hattori, Naoko; Nakamura, Yoshiaki; Kimura, Kana; Imai, Toshio; Maeda, Masahiro; Yashiro, Masakazu; Ushijima, Toshikazu

Moro, Hiroshi; Hattori, Naoko; Nakamura, Yoshiaki; Kimura, Kana; Imai, Toshio; Maeda, Masahiro; Yashiro, Masakazu; Ushijima, Toshikazu.

Afiliación

Moro H; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Hattori N; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nakamura Y; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Kimura K; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Imai T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Maeda M; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Yashiro M; Central Animal Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Ushijima T; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.

Gastric Cancer ; 23(1): 116-117, 2020 01.

Article en En | MEDLINE | ID: mdl-31729582

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google